about
Skin Pigmentation and Pigmentary Disorders: Focus on Epidermal/Dermal Cross-TalkRecent advances in understanding vitiligoEvidence-based management of vitiligo: summary of a Cochrane systematic review.The Prevalence of Vitiligo: A Meta-Analysis.Understanding mechanisms of autoimmunity through translational research in vitiligo.Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin.Network pharmacological mechanisms of Vernonia anthelmintica (L.) in the treatment of vitiligo: Isorhamnetin induction of melanogenesis via up-regulation of melanin-biosynthetic genes.The patterns of birthmarks suggest a novel population of melanocyte precursors arising around the time of gastrulation.The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.Dissecting Wnt signaling for melanocyte regulation during wound healing.Clinical and Molecular Aspects of Vitiligo Treatments.
P2860
Q26747625-A0CECB18-C806-44CA-9D94-70CD5C452F32Q28078377-156096AE-00C3-414B-BBE8-3F3718E5DDAAQ34505853-53C19C8C-36B7-4051-B030-44C3F2C0E7C3Q36145882-B5519B37-B3F8-4F4D-A847-5635947D9B86Q38808662-A112373D-72D6-4488-A66F-660B2EC51BABQ39419931-14E61E91-74EB-4ACC-BF0A-12D75A22D83CQ45070729-78D08729-0FF5-4BC1-A872-BA448BDD0082Q47395062-7641E6B7-1DAC-4ED7-A696-7712EFCDFCA9Q48302604-43073F51-61A0-4C77-8C59-324364CC0F98Q48333222-8FCC0EDB-5C7C-4315-AF11-51C9F0D51634Q50083526-BF6967C7-CD56-4352-A109-ED0C8AD9221DQ55182663-3742C9D2-7309-4C26-BF3F-651A613841C8
P2860
description
article
@en
наукова стаття, опублікована в червні 2015
@uk
name
Vitiligo
@en
type
label
Vitiligo
@en
prefLabel
Vitiligo
@en
P2093
P2860
P356
P1476
Vitiligo
@en
P2093
Alain Taieb
Davinder Parsad
Iltefat Hamzavi
John E. Harris
Maria L. Dell'Anna
P2860
P2888
P356
10.1038/NRDP.2015.11
P577
2015-06-04T00:00:00Z